<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="outc_bc_rel4" dataset_id="pht003401.v3" study_name="Women's Health Initiative" study_id="phs000200.v11" participant_set="3" date_created="06/14/2017"><description>Outcomes - Breast Cancer (Form 122/130)</description><variable id="phv00192450.v3.p3" var_name="SUBJID" calculated_type="string" reported_type="integer"><description>WHI dbGaP Subject ID</description><total><subject_profile><sex><female>11457</female></sex></subject_profile><stats><stat n="11457" nulls="0"/></stats></total></variable><variable id="phv00192450.v3.p3.c1" var_name="SUBJID" calculated_type="string" reported_type="integer"><description>WHI dbGaP Subject ID</description><total><subject_profile><sex><female>10519</female></sex></subject_profile><stats><stat n="10519" nulls="0"/></stats></total></variable><variable id="phv00192450.v3.p3.c2" var_name="SUBJID" calculated_type="string" reported_type="integer"><description>WHI dbGaP Subject ID</description><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0"/></stats></total></variable><variable id="phv00192451.v3.p3" var_name="ASCSOURCE" calculated_type="enum_integer" reported_type="encoded value"><description>Ascertainment Source</description><total><subject_profile><sex><female>11457</female></sex></subject_profile><stats><stat n="11457" nulls="0" mean_count="5729" sd="8100" median_count="5729" min_count="1" max_count="11456"/><enum code="2" count="11456">Central Form 130</enum><enum code="1" count="1">Local Form 122</enum></stats></total></variable><variable id="phv00192451.v3.p3.c1" var_name="ASCSOURCE" calculated_type="enum_integer" reported_type="encoded value"><description>Ascertainment Source</description><total><subject_profile><sex><female>10519</female></sex></subject_profile><stats><stat n="10519" nulls="0" mean_count="5260" sd="7437" median_count="5260" min_count="1" max_count="10518"/><enum code="2" count="10518">Central Form 130</enum><enum code="1" count="1">Local Form 122</enum></stats></total></variable><variable id="phv00192451.v3.p3.c2" var_name="ASCSOURCE" calculated_type="enum_integer" reported_type="encoded value"><description>Ascertainment Source</description><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="938" median_count="938" min_count="938" max_count="938"/><enum code="2" count="938">Central Form 130</enum></stats></total></variable><variable id="phv00192452.v3.p3" var_name="BREASTINV" calculated_type="string" reported_type="encoded value"><description>Breast Cancer Invasive</description><comment>Defined as a breast cancer from a Death or the first adjudication where the form 122 or 130 details indicate an invasive cancer. Breast Cancer Invasive is adjudicated for CT and OS participants. WHI adjudicated all reports of breast cancer for a ppt until the first invasive Breast Cancer. i.e. The first Invasive Breast Cancer may not be the first Breast Cancer. This file does not include cancers determined solely by the cause of death.</comment><total><subject_profile><sex><female>9291</female></sex></subject_profile><stats><stat n="9291" nulls="2166"/><enum code="1" count="9291">Yes</enum></stats></total></variable><variable id="phv00192452.v3.p3.c1" var_name="BREASTINV" calculated_type="string" reported_type="encoded value"><description>Breast Cancer Invasive</description><comment>Defined as a breast cancer from a Death or the first adjudication where the form 122 or 130 details indicate an invasive cancer. Breast Cancer Invasive is adjudicated for CT and OS participants. WHI adjudicated all reports of breast cancer for a ppt until the first invasive Breast Cancer. i.e. The first Invasive Breast Cancer may not be the first Breast Cancer. This file does not include cancers determined solely by the cause of death.</comment><total><subject_profile><sex><female>8478</female></sex></subject_profile><stats><stat n="8478" nulls="2041"/><enum code="1" count="8478">Yes</enum></stats></total></variable><variable id="phv00192452.v3.p3.c2" var_name="BREASTINV" calculated_type="string" reported_type="encoded value"><description>Breast Cancer Invasive</description><comment>Defined as a breast cancer from a Death or the first adjudication where the form 122 or 130 details indicate an invasive cancer. Breast Cancer Invasive is adjudicated for CT and OS participants. WHI adjudicated all reports of breast cancer for a ppt until the first invasive Breast Cancer. i.e. The first Invasive Breast Cancer may not be the first Breast Cancer. This file does not include cancers determined solely by the cause of death.</comment><total><subject_profile><sex><female>813</female></sex></subject_profile><stats><stat n="813" nulls="125"/><enum code="1" count="813">Yes</enum></stats></total></variable><variable id="phv00192453.v3.p3" var_name="BREASTINSITU" calculated_type="string" reported_type="encoded value"><description>Breast Cancer In Situ</description><comment>Defined as the first breast cancer where the form 122 or 130 details indicate an in situ cancer. Breast Cancer In Situ is adjudicated for CT and OS participants. Breast Cancer In Situ occurring on or after a Breast Cancer Invasive is not counted.</comment><total><subject_profile><sex><female>2166</female></sex></subject_profile><stats><stat n="2166" nulls="9291"/><enum code="1" count="2166">Yes</enum></stats></total></variable><variable id="phv00192453.v3.p3.c1" var_name="BREASTINSITU" calculated_type="string" reported_type="encoded value"><description>Breast Cancer In Situ</description><comment>Defined as the first breast cancer where the form 122 or 130 details indicate an in situ cancer. Breast Cancer In Situ is adjudicated for CT and OS participants. Breast Cancer In Situ occurring on or after a Breast Cancer Invasive is not counted.</comment><total><subject_profile><sex><female>2041</female></sex></subject_profile><stats><stat n="2041" nulls="8478"/><enum code="1" count="2041">Yes</enum></stats></total></variable><variable id="phv00192453.v3.p3.c2" var_name="BREASTINSITU" calculated_type="string" reported_type="encoded value"><description>Breast Cancer In Situ</description><comment>Defined as the first breast cancer where the form 122 or 130 details indicate an in situ cancer. Breast Cancer In Situ is adjudicated for CT and OS participants. Breast Cancer In Situ occurring on or after a Breast Cancer Invasive is not counted.</comment><total><subject_profile><sex><female>125</female></sex></subject_profile><stats><stat n="125" nulls="813"/><enum code="1" count="125">Yes</enum></stats></total></variable><variable id="phv00192454.v3.p3" var_name="ICDCODE" calculated_type="enum_integer" reported_type="string"><description>ICD-O-2 site code</description><comment>All centrally adjudicated cancers (F130) have an ICD-O-2 code. The only locally adjudicated cancers with a code are those marked as 'other' on F122. F122 codes do not include a decimal. See the SEER coding section of the data prep/use document for details. A description of the ICD site codes can be found in the reference file seer_icd_site_codes.dat by merging on the ICDCODE variable.</comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean_count="1273" sd="1202" median_count="956" min_count="43" max_count="3933"/><enum code="50.4" count="3933">Upper outer quadrant of breast</enum><enum code="50.8" count="2294">Overlapping lesion of breast</enum><enum code="50.2" count="1282">Upper inner quadrant of breast</enum><enum code="50.9" count="1229">Breast NOS (excludes Skin of breast C44.5)</enum><enum code="50.1" count="956">Central portion of breast</enum><enum code="50.5" count="883">Lower outer quadrant of breast</enum><enum code="50.3" count="741">Lower inner quadrant of breast</enum><enum code="50.6" count="95">Axillary tail of breast</enum><enum code="50.0" count="43">Nipple</enum></stats></total></variable><variable id="phv00192454.v3.p3.c1" var_name="ICDCODE" calculated_type="enum_integer" reported_type="string"><description>ICD-O-2 site code</description><comment>All centrally adjudicated cancers (F130) have an ICD-O-2 code. The only locally adjudicated cancers with a code are those marked as 'other' on F122. F122 codes do not include a decimal. See the SEER coding section of the data prep/use document for details. A description of the ICD site codes can be found in the reference file seer_icd_site_codes.dat by merging on the ICDCODE variable.</comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean_count="1169" sd="1107" median_count="898" min_count="38" max_count="3631"/><enum code="50.4" count="3631">Upper outer quadrant of breast</enum><enum code="50.8" count="2100">Overlapping lesion of breast</enum><enum code="50.2" count="1177">Upper inner quadrant of breast</enum><enum code="50.9" count="1066">Breast NOS (excludes Skin of breast C44.5)</enum><enum code="50.1" count="898">Central portion of breast</enum><enum code="50.5" count="819">Lower outer quadrant of breast</enum><enum code="50.3" count="703">Lower inner quadrant of breast</enum><enum code="50.6" count="86">Axillary tail of breast</enum><enum code="50.0" count="38">Nipple</enum></stats></total></variable><variable id="phv00192454.v3.p3.c2" var_name="ICDCODE" calculated_type="enum_integer" reported_type="string"><description>ICD-O-2 site code</description><comment>All centrally adjudicated cancers (F130) have an ICD-O-2 code. The only locally adjudicated cancers with a code are those marked as 'other' on F122. F122 codes do not include a decimal. See the SEER coding section of the data prep/use document for details. A description of the ICD site codes can be found in the reference file seer_icd_site_codes.dat by merging on the ICDCODE variable.</comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="104.2" sd="98.54" median_count="64" min_count="5" max_count="302"/><enum code="50.4" count="302">Upper outer quadrant of breast</enum><enum code="50.8" count="194">Overlapping lesion of breast</enum><enum code="50.9" count="163">Breast NOS (excludes Skin of breast C44.5)</enum><enum code="50.2" count="105">Upper inner quadrant of breast</enum><enum code="50.5" count="64">Lower outer quadrant of breast</enum><enum code="50.1" count="58">Central portion of breast</enum><enum code="50.3" count="38">Lower inner quadrant of breast</enum><enum code="50.6" count="9">Axillary tail of breast</enum><enum code="50.0" count="5">Nipple</enum></stats></total></variable><variable id="phv00192455.v3.p3" var_name="BEHAVIOR" calculated_type="enum_integer" reported_type="encoded value"><description>Tumor Behavior</description><comment>For cancers that have been SEER coded, tumor behavior comes from the 5th digit of the morphology (see MRPHHISTB). For cancers that have not been SEER coded, F130/Question 3 or F122/Question 4 is used.</comment><total><subject_profile><sex><female>11457</female></sex></subject_profile><stats><stat n="11457" nulls="0" mean_count="5729" sd="5038" median_count="5729" min_count="2166" max_count="9291"/><enum code="1" count="9291">Invasive</enum><enum code="2" count="2166">In Situ</enum></stats></total></variable><variable id="phv00192455.v3.p3.c1" var_name="BEHAVIOR" calculated_type="enum_integer" reported_type="encoded value"><description>Tumor Behavior</description><comment>For cancers that have been SEER coded, tumor behavior comes from the 5th digit of the morphology (see MRPHHISTB). For cancers that have not been SEER coded, F130/Question 3 or F122/Question 4 is used.</comment><total><subject_profile><sex><female>10519</female></sex></subject_profile><stats><stat n="10519" nulls="0" mean_count="5260" sd="4552" median_count="5260" min_count="2041" max_count="8478"/><enum code="1" count="8478">Invasive</enum><enum code="2" count="2041">In Situ</enum></stats></total></variable><variable id="phv00192455.v3.p3.c2" var_name="BEHAVIOR" calculated_type="enum_integer" reported_type="encoded value"><description>Tumor Behavior</description><comment>For cancers that have been SEER coded, tumor behavior comes from the 5th digit of the morphology (see MRPHHISTB). For cancers that have not been SEER coded, F130/Question 3 or F122/Question 4 is used.</comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="469" sd="486.5" median_count="469" min_count="125" max_count="813"/><enum code="1" count="813">Invasive</enum><enum code="2" count="125">In Situ</enum></stats></total></variable><variable id="phv00192456.v3.p3" var_name="RPRTSRC" calculated_type="enum_integer" reported_type="encoded value"><description>Reporting source</description><comment>Reporting Source: (Mark only one. If more than one category applies, mark the first applicable category.)</comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean_count="2291" sd="3226" median_count="21" min_count="2" max_count="6849"/><enum code="2" count="6849">Hospital outpatient/radiation/chemo, surgical center, clinic</enum><enum code="1" count="4579">Hospital inpatient</enum><enum code="3" count="21">Laboratory only including pathology office</enum><enum code="7" count="5">Death certificate only</enum><enum code="4" count="2">Physician's office/private medical practitioner</enum></stats></total></variable><variable id="phv00192456.v3.p3.c1" var_name="RPRTSRC" calculated_type="enum_integer" reported_type="encoded value"><description>Reporting source</description><comment>Reporting Source: (Mark only one. If more than one category applies, mark the first applicable category.)</comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean_count="2630" sd="3177" median_count="2038" min_count="1" max_count="6441"/><enum code="2" count="6441">Hospital outpatient/radiation/chemo, surgical center, clinic</enum><enum code="1" count="4055">Hospital inpatient</enum><enum code="3" count="21">Laboratory only including pathology office</enum><enum code="4" count="1">Physician's office/private medical practitioner</enum></stats></total></variable><variable id="phv00192456.v3.p3.c2" var_name="RPRTSRC" calculated_type="enum_integer" reported_type="encoded value"><description>Reporting source</description><comment>Reporting Source: (Mark only one. If more than one category applies, mark the first applicable category.)</comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="234.5" sd="271.5" median_count="206.5" min_count="1" max_count="524"/><enum code="1" count="524">Hospital inpatient</enum><enum code="2" count="408">Hospital outpatient/radiation/chemo, surgical center, clinic</enum><enum code="7" count="5">Death certificate only</enum><enum code="4" count="1">Physician's office/private medical practitioner</enum></stats></total></variable><variable id="phv00192457.v3.p3" var_name="DIAGSTAT" calculated_type="enum_integer" reported_type="encoded value"><description>Diagnostic confirmation status</description><comment>Diagnostic Confirmation Status: (Mark only one. If more than one category applies, mark the first applicable category.)</comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean_count="1432" sd="4015" median_count="5" min_count="1" max_count="11369"/><enum code="1" count="11369">Positive histology (pathology)</enum><enum code="3" count="61">Positive histology (pathology), regional/distant meta. site</enum><enum code="2" count="12">Positive exfoliative cytology, no positive histology</enum><enum code="7" count="6">Radiography &amp; other imaging techniques w/o micro confirm</enum><enum code="9" count="4">Unknown if microscopically confirmed</enum><enum code="8" count="2">Clinical diagnosis only (other than 5, 6, 7)</enum><enum code="4" count="1">Positive micro confirmation, method not specified</enum><enum code="5" count="1">Positive laboratory test/marker study</enum></stats></total></variable><variable id="phv00192457.v3.p3.c1" var_name="DIAGSTAT" calculated_type="enum_integer" reported_type="encoded value"><description>Diagnostic confirmation status</description><comment>Diagnostic Confirmation Status: (Mark only one. If more than one category applies, mark the first applicable category.)</comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean_count="2104" sd="4667" median_count="8" min_count="2" max_count="10452"/><enum code="1" count="10452">Positive histology (pathology)</enum><enum code="3" count="50">Positive histology (pathology), regional/distant meta. site</enum><enum code="2" count="8">Positive exfoliative cytology, no positive histology</enum><enum code="7" count="6">Radiography &amp; other imaging techniques w/o micro confirm</enum><enum code="8" count="2">Clinical diagnosis only (other than 5, 6, 7)</enum></stats></total></variable><variable id="phv00192457.v3.p3.c2" var_name="DIAGSTAT" calculated_type="enum_integer" reported_type="encoded value"><description>Diagnostic confirmation status</description><comment>Diagnostic Confirmation Status: (Mark only one. If more than one category applies, mark the first applicable category.)</comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="156.3" sd="372.7" median_count="4" min_count="1" max_count="917"/><enum code="1" count="917">Positive histology (pathology)</enum><enum code="3" count="11">Positive histology (pathology), regional/distant meta. site</enum><enum code="9" count="4">Unknown if microscopically confirmed</enum><enum code="2" count="4">Positive exfoliative cytology, no positive histology</enum><enum code="4" count="1">Positive micro confirmation, method not specified</enum><enum code="5" count="1">Positive laboratory test/marker study</enum></stats></total></variable><variable id="phv00192458.v3.p3" var_name="LATERAL" calculated_type="enum_integer" reported_type="encoded value"><description>Laterality</description><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean_count="2864" sd="3295" median_count="2792" min_count="1" max_count="5872"/><enum code="2" count="5872">Left - origin of primary</enum><enum code="1" count="5558">Right - origin of primary</enum><enum code="5" count="25">Paired site, no lateral info, midline tumor</enum><enum code="3" count="1">Only one side right or left unspecified</enum></stats></total></variable><variable id="phv00192458.v3.p3.c1" var_name="LATERAL" calculated_type="enum_integer" reported_type="encoded value"><description>Laterality</description><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean_count="2630" sd="3030" median_count="2555" min_count="1" max_count="5407"/><enum code="2" count="5407">Left - origin of primary</enum><enum code="1" count="5096">Right - origin of primary</enum><enum code="5" count="14">Paired site, no lateral info, midline tumor</enum><enum code="3" count="1">Only one side right or left unspecified</enum></stats></total></variable><variable id="phv00192458.v3.p3.c2" var_name="LATERAL" calculated_type="enum_integer" reported_type="encoded value"><description>Laterality</description><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="312.7" sd="261.3" median_count="462" min_count="11" max_count="465"/><enum code="2" count="465">Left - origin of primary</enum><enum code="1" count="462">Right - origin of primary</enum><enum code="5" count="11">Paired site, no lateral info, midline tumor</enum></stats></total></variable><variable id="phv00192459.v3.p3" var_name="MRPHHISTB" calculated_type="enum_integer" reported_type="string"><description>Morphology - histology/behavior</description><comment>Morphology: first 5 digits
		ICD-O-2 codes were used for all cancers except Lymphoma and Leukemia. WHI used ICD-O-3 codes for those cancers. WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. A description of the histology/behavior codes can be found in the reference file seer_icd_hist_codes.dat by merging on the MRPHHISTB variable. </comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean_count="161.4" sd="731.9" median_count="4" min_count="1" max_count="5978" distinct_vals="71"/><example code="8500/3" count="5978">INFILTRATING DUCT CARCINOMA</example><example code="8522/3" count="1299">INFILTRATING DUCT AND LOBULAR CARCINOMA</example><example code="8520/3" count="943">LOBULAR CARCINOMA NOS</example><example code="8500/2" count="591">INTRADUCTAL CARCINOMA, NONINFILTRATING, NOS</example><example code="8230/2" count="428">DUCTAL CARCINOMA IN SITU, SOLID TYPE</example><example code="8501/2" count="390">COMEDOCARCINOMA, NONINFILTRATING</example><example code="8480/3" count="350">MUCOUS ADENOCARCINOMA</example><example code="8201/2" count="315">CRIBRIFORM CARCINOMA IN SITU</example><example code="8211/3" count="250">TUBULAR ADENOCARCINOMA</example><example code="8503/2" count="127">NONINFILTRATING ADENOCARCINOMA, INTRADUCTAL, PAPILLARY</example></stats></total></variable><variable id="phv00192459.v3.p3.c1" var_name="MRPHHISTB" calculated_type="enum_integer" reported_type="string"><description>Morphology - histology/behavior</description><comment>Morphology: first 5 digits
		ICD-O-2 codes were used for all cancers except Lymphoma and Leukemia. WHI used ICD-O-3 codes for those cancers. WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. A description of the histology/behavior codes can be found in the reference file seer_icd_hist_codes.dat by merging on the MRPHHISTB variable. </comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean_count="150.3" sd="672.4" median_count="3.5" min_count="1" max_count="5448" distinct_vals="70"/><example code="8500/3" count="5448">INFILTRATING DUCT CARCINOMA</example><example code="8522/3" count="1200">INFILTRATING DUCT AND LOBULAR CARCINOMA</example><example code="8520/3" count="862">LOBULAR CARCINOMA NOS</example><example code="8500/2" count="560">INTRADUCTAL CARCINOMA, NONINFILTRATING, NOS</example><example code="8230/2" count="406">DUCTAL CARCINOMA IN SITU, SOLID TYPE</example><example code="8501/2" count="365">COMEDOCARCINOMA, NONINFILTRATING</example><example code="8480/3" count="326">MUCOUS ADENOCARCINOMA</example><example code="8201/2" count="295">CRIBRIFORM CARCINOMA IN SITU</example><example code="8211/3" count="234">TUBULAR ADENOCARCINOMA</example><example code="8503/2" count="120">NONINFILTRATING ADENOCARCINOMA, INTRADUCTAL, PAPILLARY</example></stats></total></variable><variable id="phv00192459.v3.p3.c2" var_name="MRPHHISTB" calculated_type="enum_integer" reported_type="string"><description>Morphology - histology/behavior</description><comment>Morphology: first 5 digits
		ICD-O-2 codes were used for all cancers except Lymphoma and Leukemia. WHI used ICD-O-3 codes for those cancers. WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. A description of the histology/behavior codes can be found in the reference file seer_icd_hist_codes.dat by merging on the MRPHHISTB variable. </comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="27.59" sd="91.33" median_count="4" min_count="1" max_count="530"/><example code="8500/3" count="530">INFILTRATING DUCT CARCINOMA</example><example code="8522/3" count="99">INFILTRATING DUCT AND LOBULAR CARCINOMA</example><example code="8520/3" count="81">LOBULAR CARCINOMA NOS</example><example code="8500/2" count="31">INTRADUCTAL CARCINOMA, NONINFILTRATING, NOS</example><example code="8501/2" count="25">COMEDOCARCINOMA, NONINFILTRATING</example><example code="8480/3" count="24">MUCOUS ADENOCARCINOMA</example><example code="8230/2" count="22">DUCTAL CARCINOMA IN SITU, SOLID TYPE</example><example code="8201/2" count="20">CRIBRIFORM CARCINOMA IN SITU</example><example code="8211/3" count="16">TUBULAR ADENOCARCINOMA</example><example code="8010/3" count="13">CARCINOMA NOS</example></stats></total></variable><variable id="phv00192460.v3.p3" var_name="GRADING" calculated_type="enum_integer" reported_type="encoded value"><description>Morphology - grading</description><comment>Morphology: 6th digit
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean_count="2291" sd="1555" median_count="2574" min_count="599" max_count="4545"/><enum code="2" count="4545">Moderately differentiated</enum><enum code="3" count="2672">Poorly differentiated</enum><enum code="1" count="2574">Well differentiated</enum><enum code="9" count="1066">Unknown/not done</enum><enum code="4" count="599">Anaplastic</enum></stats></total></variable><variable id="phv00192460.v3.p3.c1" var_name="GRADING" calculated_type="enum_integer" reported_type="encoded value"><description>Morphology - grading</description><comment>Morphology: 6th digit
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean_count="2104" sd="1464" median_count="2408" min_count="539" max_count="4221"/><enum code="2" count="4221">Moderately differentiated</enum><enum code="1" count="2442">Well differentiated</enum><enum code="3" count="2408">Poorly differentiated</enum><enum code="9" count="908">Unknown/not done</enum><enum code="4" count="539">Anaplastic</enum></stats></total></variable><variable id="phv00192460.v3.p3.c2" var_name="GRADING" calculated_type="enum_integer" reported_type="encoded value"><description>Morphology - grading</description><comment>Morphology: 6th digit
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="187.6" sd="105.7" median_count="158" min_count="60" max_count="324"/><enum code="2" count="324">Moderately differentiated</enum><enum code="3" count="264">Poorly differentiated</enum><enum code="9" count="158">Unknown/not done</enum><enum code="1" count="132">Well differentiated</enum><enum code="4" count="60">Anaplastic</enum></stats></total></variable><variable id="phv00192461.v3.p3" var_name="SIZE" calculated_type="integer" reported_type="decimal"><description>F130 EOD SEER - Size</description><comment>Evidence of Disease (SEER): digits 1-3
		When size doesnt make sense, this field is used for other purposes (e.g. Leukemias have no size, this field records AIDS status). Size is usually measured in mm, though it may vary by cancer type. Even for cancers that do have a size, not all values indicate an actual size (e.g. 2 for many cancers means '&lt;=2mm', but for breast cancer it means 'Mammographic diagnosis only, tumor not clinically palpable' ). WHI used the SEER 1988, 2nd edition rules for coding cancers. See the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean="86.07" sd="254.1" median="13" min="0" max="999"/><example count="794">10</example><example count="787">999</example><example count="784">15</example><example count="584">8</example><example count="579">12</example><example count="516">20</example><example count="499">9</example><example count="479">7</example><example count="477">3</example><example count="466">5</example></stats></total></variable><variable id="phv00192461.v3.p3.c1" var_name="SIZE" calculated_type="integer" reported_type="decimal"><description>F130 EOD SEER - Size</description><comment>Evidence of Disease (SEER): digits 1-3
		When size doesnt make sense, this field is used for other purposes (e.g. Leukemias have no size, this field records AIDS status). Size is usually measured in mm, though it may vary by cancer type. Even for cancers that do have a size, not all values indicate an actual size (e.g. 2 for many cancers means '&lt;=2mm', but for breast cancer it means 'Mammographic diagnosis only, tumor not clinically palpable' ). WHI used the SEER 1988, 2nd edition rules for coding cancers. See the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean="83.55" sd="250.3" median="13" min="0" max="999"/><example count="718">10</example><example count="711">15</example><example count="711">999</example><example count="546">8</example><example count="542">12</example><example count="470">20</example><example count="466">9</example><example count="454">7</example><example count="442">3</example><example count="441">5</example></stats></total></variable><variable id="phv00192461.v3.p3.c2" var_name="SIZE" calculated_type="integer" reported_type="decimal"><description>F130 EOD SEER - Size</description><comment>Evidence of Disease (SEER): digits 1-3
		When size doesnt make sense, this field is used for other purposes (e.g. Leukemias have no size, this field records AIDS status). Size is usually measured in mm, though it may vary by cancer type. Even for cancers that do have a size, not all values indicate an actual size (e.g. 2 for many cancers means '&lt;=2mm', but for breast cancer it means 'Mammographic diagnosis only, tumor not clinically palpable' ). WHI used the SEER 1988, 2nd edition rules for coding cancers. See the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean="114.4" sd="292.2" median="15" min="0" max="999"/><example count="76">999</example><example count="76">10</example><example count="73">15</example><example count="46">20</example><example count="41">1</example><example count="41">30</example><example count="38">8</example><example count="37">12</example><example count="36">25</example><example count="35">3</example></stats></total></variable><variable id="phv00192462.v3.p3" var_name="EXTENSION" calculated_type="integer" reported_type="integer"><description>F130 EOD SEER - Extension</description><comment>Evidence of Disease (SEER): digits 4-5
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean="10.37" sd="13.23" median="10" min="0" max="99"/><example count="8752">10</example><example count="2128">0</example><example count="174">20</example><example count="129">85</example><example count="102">99</example><example count="41">5</example><example count="41">70</example><example count="33">30</example><example count="29">50</example><example count="23">40</example></stats></total></variable><variable id="phv00192462.v3.p3.c1" var_name="EXTENSION" calculated_type="integer" reported_type="integer"><description>F130 EOD SEER - Extension</description><comment>Evidence of Disease (SEER): digits 4-5
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean="9.956" sd="12.21" median="10" min="0" max="99"/><example count="8046">10</example><example count="2008">0</example><example count="152">20</example><example count="94">85</example><example count="81">99</example><example count="34">5</example><example count="28">70</example><example count="27">50</example><example count="25">30</example><example count="21">40</example></stats></total></variable><variable id="phv00192462.v3.p3.c2" var_name="EXTENSION" calculated_type="integer" reported_type="integer"><description>F130 EOD SEER - Extension</description><comment>Evidence of Disease (SEER): digits 4-5
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean="14.97" sd="21.03" median="10" min="0" max="99"/><example count="706">10</example><example count="120">0</example><example count="35">85</example><example count="22">20</example><example count="21">99</example><example count="13">70</example><example count="8">30</example><example count="7">5</example><example count="2">60</example><example count="2">50</example></stats></total></variable><variable id="phv00192463.v3.p3" var_name="INVOLVE" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Lymph node involvement</description><comment>Evidence of Disease (SEER): digit 6
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean="0.863" sd="2.049" median="0" min="0" max="9"/><enum count="9155">0</enum><enum count="600">6</enum><enum count="490">2</enum><enum count="301">1</enum><enum count="289">3</enum><enum count="277">5</enum><enum count="244">9</enum><enum count="60">4</enum><enum count="38">8</enum><enum count="2">7</enum></stats></total></variable><variable id="phv00192463.v3.p3.c1" var_name="INVOLVE" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Lymph node involvement</description><comment>Evidence of Disease (SEER): digit 6
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean="0.7788" sd="1.935" median="0" min="0" max="9"/><enum count="8531">0</enum><enum count="495">6</enum><enum count="452">2</enum><enum count="285">1</enum><enum count="265">3</enum><enum count="215">5</enum><enum count="188">9</enum><enum count="56">4</enum><enum count="29">8</enum><enum count="2">7</enum></stats></total></variable><variable id="phv00192463.v3.p3.c2" var_name="INVOLVE" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Lymph node involvement</description><comment>Evidence of Disease (SEER): digit 6
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean="1.808" sd="2.89" median="0" min="0" max="9"/><enum count="624">0</enum><enum count="105">6</enum><enum count="62">5</enum><enum count="56">9</enum><enum count="38">2</enum><enum count="24">3</enum><enum count="16">1</enum><enum count="9">8</enum><enum count="4">4</enum></stats></total></variable><variable id="phv00192464.v3.p3" var_name="POSLYMPH" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Number of positive lymph nodes</description><comment>Evidence of Disease (SEER): digits 7-8
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean="24.2" sd="41.62" median="0" min="0" max="99"/><example count="6743">0</example><example count="2662">98</example><example count="919">1</example><example count="360">2</example><example count="159">3</example><example count="107">4</example><example count="80">5</example><example count="65">99</example><example count="48">6</example><example count="37">7</example></stats></total></variable><variable id="phv00192464.v3.p3.c1" var_name="POSLYMPH" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Number of positive lymph nodes</description><comment>Evidence of Disease (SEER): digits 7-8
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean="23.77" sd="41.43" median="0" min="0" max="99"/><example count="6301">0</example><example count="2427">98</example><example count="845">1</example><example count="322">2</example><example count="136">3</example><example count="92">4</example><example count="69">5</example><example count="42">99</example><example count="41">6</example><example count="30">7</example></stats></total></variable><variable id="phv00192464.v3.p3.c2" var_name="POSLYMPH" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Number of positive lymph nodes</description><comment>Evidence of Disease (SEER): digits 7-8
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean="28.99" sd="43.45" median="1" min="0" max="99"/><example count="442">0</example><example count="235">98</example><example count="74">1</example><example count="38">2</example><example count="23">99</example><example count="23">3</example><example count="15">4</example><example count="11">5</example><example count="9">14</example><example count="9">8</example></stats></total></variable><variable id="phv00192465.v3.p3" var_name="NUMLYMPH" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Number of lymph nodes examined</description><comment>Evidence of Disease (SEER): digits 9-10
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>11456</female></sex></subject_profile><stats><stat n="11456" nulls="1" mean="7.04" sd="12.41" median="3" min="0" max="99"/><example count="2663">0</example><example count="1518">1</example><example count="1417">2</example><example count="797">3</example><example count="536">4</example><example count="375">5</example><example count="313">6</example><example count="271">7</example><example count="270">11</example><example count="270">10</example></stats></total></variable><variable id="phv00192465.v3.p3.c1" var_name="NUMLYMPH" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Number of lymph nodes examined</description><comment>Evidence of Disease (SEER): digits 9-10
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>10518</female></sex></subject_profile><stats><stat n="10518" nulls="1" mean="6.567" sd="11.55" median="2" min="0" max="99"/><example count="2428">0</example><example count="1473">1</example><example count="1372">2</example><example count="766">3</example><example count="516">4</example><example count="347">5</example><example count="291">6</example><example count="253">7</example><example count="243">8</example><example count="236">10</example></stats></total></variable><variable id="phv00192465.v3.p3.c2" var_name="NUMLYMPH" calculated_type="integer" reported_type="integer"><description>F130 EOD (SEER) - Number of lymph nodes examined</description><comment>Evidence of Disease (SEER): digits 9-10
		WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details. </comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean="12.35" sd="18.84" median="9" min="0" max="99"/><example count="235">0</example><example count="45">1</example><example count="45">2</example><example count="38">11</example><example count="34">18</example><example count="34">10</example><example count="33">16</example><example count="31">13</example><example count="31">3</example><example count="29">15</example></stats></total></variable><variable id="phv00192466.v3.p3" var_name="STAGE" calculated_type="enum_integer" reported_type="encoded value"><description>Summary Stage (SEER)</description><comment>WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details.</comment><total><subject_profile><sex><female>11455</female></sex></subject_profile><stats><stat n="11455" nulls="2" mean_count="2291" sd="2788" median_count="2103" min_count="105" max_count="6943"/><enum code="2" count="6943">Localized</enum><enum code="1" count="2161">In Situ</enum><enum code="3" count="2103">Regional</enum><enum code="4" count="143">Distant</enum><enum code="9" count="105">Unknown</enum></stats></total></variable><variable id="phv00192466.v3.p3.c1" var_name="STAGE" calculated_type="enum_integer" reported_type="encoded value"><description>Summary Stage (SEER)</description><comment>WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details.</comment><total><subject_profile><sex><female>10517</female></sex></subject_profile><stats><stat n="10517" nulls="2" mean_count="2103" sd="2598" median_count="1857" min_count="75" max_count="6442"/><enum code="2" count="6442">Localized</enum><enum code="1" count="2037">In Situ</enum><enum code="3" count="1857">Regional</enum><enum code="4" count="106">Distant</enum><enum code="9" count="75">Unknown</enum></stats></total></variable><variable id="phv00192466.v3.p3.c2" var_name="STAGE" calculated_type="enum_integer" reported_type="encoded value"><description>Summary Stage (SEER)</description><comment>WHI used SEER 1988, 2nd edition rules when coding cancers, see the SEER coding section of the data prep/use document for details.</comment><total><subject_profile><sex><female>938</female></sex></subject_profile><stats><stat n="938" nulls="0" mean_count="187.6" sd="195.7" median_count="124" min_count="30" max_count="501"/><enum code="2" count="501">Localized</enum><enum code="3" count="246">Regional</enum><enum code="1" count="124">In Situ</enum><enum code="4" count="37">Distant</enum><enum code="9" count="30">Unknown</enum></stats></total></variable><variable id="phv00192467.v3.p3" var_name="HIST8522" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Breast Histology 8522 Subclass</description><comment>Subclassification for Breast Histology 8522.
		Not collected on early versions of F130. </comment><total><subject_profile><sex><female>7430</female></sex></subject_profile><stats><stat n="7430" nulls="4027" mean_count="1238" sd="2350" median_count="247" min_count="119" max_count="6022"/><enum code="0" count="6022">Not Applicable</enum><enum code="3" count="625">Ductal invasive plus lobular invasive</enum><enum code="2" count="276">Ductal invasive plus lobular in situ</enum><enum code="5" count="218">Invasive cancer, ductal and lobular nos</enum><enum code="4" count="170">Lobular invasive plus ductal in situ</enum><enum code="1" count="119">Ductal in situ plus lobular in situ</enum></stats></total></variable><variable id="phv00192467.v3.p3.c1" var_name="HIST8522" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Breast Histology 8522 Subclass</description><comment>Subclassification for Breast Histology 8522.
		Not collected on early versions of F130. </comment><total><subject_profile><sex><female>7193</female></sex></subject_profile><stats><stat n="7193" nulls="3326" mean_count="1199" sd="2301" median_count="238" min_count="117" max_count="5884"/><enum code="0" count="5884">Not Applicable</enum><enum code="3" count="562">Ductal invasive plus lobular invasive</enum><enum code="2" count="259">Ductal invasive plus lobular in situ</enum><enum code="5" count="217">Invasive cancer, ductal and lobular nos</enum><enum code="4" count="154">Lobular invasive plus ductal in situ</enum><enum code="1" count="117">Ductal in situ plus lobular in situ</enum></stats></total></variable><variable id="phv00192467.v3.p3.c2" var_name="HIST8522" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Breast Histology 8522 Subclass</description><comment>Subclassification for Breast Histology 8522.
		Not collected on early versions of F130. </comment><total><subject_profile><sex><female>237</female></sex></subject_profile><stats><stat n="237" nulls="701" mean_count="39.5" sd="53.29" median_count="16.5" min_count="1" max_count="138"/><enum code="0" count="138">Not Applicable</enum><enum code="3" count="63">Ductal invasive plus lobular invasive</enum><enum code="2" count="17">Ductal invasive plus lobular in situ</enum><enum code="4" count="16">Lobular invasive plus ductal in situ</enum><enum code="1" count="2">Ductal in situ plus lobular in situ</enum><enum code="5" count="1">Invasive cancer, ductal and lobular nos</enum></stats></total></variable><variable id="phv00192468.v3.p3" var_name="ERASSAY" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Estrogen receptor assay</description><total><subject_profile><sex><female>11453</female></sex></subject_profile><stats><stat n="11453" nulls="4" mean_count="2291" sd="3472" median_count="1390" min_count="15" max_count="8380"/><enum code="1" count="8380">Positive</enum><enum code="2" count="1509">Negative</enum><enum code="9" count="1390">Unknown/Not done</enum><enum code="8" count="159">Ordered/Results not available</enum><enum code="3" count="15">Borderline</enum></stats></total></variable><variable id="phv00192468.v3.p3.c1" var_name="ERASSAY" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Estrogen receptor assay</description><total><subject_profile><sex><female>10516</female></sex></subject_profile><stats><stat n="10516" nulls="3" mean_count="2103" sd="3259" median_count="1216" min_count="11" max_count="7832"/><enum code="1" count="7832">Positive</enum><enum code="2" count="1326">Negative</enum><enum code="9" count="1216">Unknown/Not done</enum><enum code="8" count="131">Ordered/Results not available</enum><enum code="3" count="11">Borderline</enum></stats></total></variable><variable id="phv00192468.v3.p3.c2" var_name="ERASSAY" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Estrogen receptor assay</description><total><subject_profile><sex><female>937</female></sex></subject_profile><stats><stat n="937" nulls="1" mean_count="187.4" sd="217.5" median_count="174" min_count="4" max_count="548"/><enum code="1" count="548">Positive</enum><enum code="2" count="183">Negative</enum><enum code="9" count="174">Unknown/Not done</enum><enum code="8" count="28">Ordered/Results not available</enum><enum code="3" count="4">Borderline</enum></stats></total></variable><variable id="phv00192469.v3.p3" var_name="ERDY" calculated_type="integer" units="days" reported_type="integer"><description>F130 Days to Estrogen Assay</description><total><subject_profile><sex><female>9916</female></sex></subject_profile><stats><stat n="9916" nulls="1541" mean="3301" sd="1953" median="3179" min="1" max="7945"/><example count="11">764</example><example count="10">3480</example><example count="7">2625</example><example count="7">5447</example><example count="7">2379</example><example count="7">3926</example><example count="7">1148</example><example count="7">3753</example><example count="7">4914</example><example count="7">5584</example></stats></total></variable><variable id="phv00192469.v3.p3.c1" var_name="ERDY" calculated_type="integer" units="days" reported_type="integer"><description>F130 Days to Estrogen Assay</description><total><subject_profile><sex><female>9179</female></sex></subject_profile><stats><stat n="9179" nulls="1340" mean="3453" sd="1929" median="3408" min="1" max="7945"/><example count="10">3480</example><example count="8">764</example><example count="7">2625</example><example count="7">5447</example><example count="7">2379</example><example count="7">3926</example><example count="7">3753</example><example count="7">5584</example><example count="7">4053</example><example count="7">4732</example></stats></total></variable><variable id="phv00192469.v3.p3.c2" var_name="ERDY" calculated_type="integer" units="days" reported_type="integer"><description>F130 Days to Estrogen Assay</description><total><subject_profile><sex><female>737</female></sex></subject_profile><stats><stat n="737" nulls="201" mean="1414" sd="1057" median="1235" min="8" max="7090"/><example count="3">451</example><example count="3">944</example><example count="3">1172</example><example count="3">743</example><example count="3">595</example><example count="3">1148</example><example count="3">373</example><example count="3">764</example><example count="2">233</example><example count="2">463</example></stats></total></variable><variable id="phv00192470.v3.p3" var_name="ERTYPE" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Type of Estrogen Assay</description><total><subject_profile><sex><female>9911</female></sex></subject_profile><stats><stat n="9911" nulls="1546" mean_count="2478" sd="4286" median_count="454.5" min_count="112" max_count="8890"/><enum code="2" count="8890">ICC/IHC</enum><enum code="9" count="771">Unknown</enum><enum code="8" count="138">Other</enum><enum code="1" count="112">fmol/mg protein</enum></stats></total></variable><variable id="phv00192470.v3.p3.c1" var_name="ERTYPE" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Type of Estrogen Assay</description><total><subject_profile><sex><female>9175</female></sex></subject_profile><stats><stat n="9175" nulls="1344" mean_count="2294" sd="3988" median_count="413" min_count="88" max_count="8261"/><enum code="2" count="8261">ICC/IHC</enum><enum code="9" count="692">Unknown</enum><enum code="8" count="134">Other</enum><enum code="1" count="88">fmol/mg protein</enum></stats></total></variable><variable id="phv00192470.v3.p3.c2" var_name="ERTYPE" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Type of Estrogen Assay</description><total><subject_profile><sex><female>736</female></sex></subject_profile><stats><stat n="736" nulls="202" mean_count="184" sd="298.4" median_count="51.5" min_count="4" max_count="629"/><enum code="2" count="629">ICC/IHC</enum><enum code="9" count="79">Unknown</enum><enum code="1" count="24">fmol/mg protein</enum><enum code="8" count="4">Other</enum></stats></total></variable><variable id="phv00192471.v3.p3" var_name="PRASSAY" calculated_type="enum_integer" reported_type="encoded value"><description>Progesterone receptor assay</description><total><subject_profile><sex><female>11453</female></sex></subject_profile><stats><stat n="11453" nulls="4" mean_count="2291" sd="2851" median_count="1540" min_count="51" max_count="7010"/><enum code="1" count="7010">Positive</enum><enum code="2" count="2686">Negative</enum><enum code="9" count="1540">Unknown/Not done</enum><enum code="8" count="166">Ordered/Results not available</enum><enum code="3" count="51">Borderline</enum></stats></total></variable><variable id="phv00192471.v3.p3.c1" var_name="PRASSAY" calculated_type="enum_integer" reported_type="encoded value"><description>Progesterone receptor assay</description><total><subject_profile><sex><female>10516</female></sex></subject_profile><stats><stat n="10516" nulls="3" mean_count="2103" sd="2685" median_count="1346" min_count="45" max_count="6581"/><enum code="1" count="6581">Positive</enum><enum code="2" count="2410">Negative</enum><enum code="9" count="1346">Unknown/Not done</enum><enum code="8" count="134">Ordered/Results not available</enum><enum code="3" count="45">Borderline</enum></stats></total></variable><variable id="phv00192471.v3.p3.c2" var_name="PRASSAY" calculated_type="enum_integer" reported_type="encoded value"><description>Progesterone receptor assay</description><total><subject_profile><sex><female>937</female></sex></subject_profile><stats><stat n="937" nulls="1" mean_count="187.4" sd="175.6" median_count="194" min_count="6" max_count="429"/><enum code="1" count="429">Positive</enum><enum code="2" count="276">Negative</enum><enum code="9" count="194">Unknown/Not done</enum><enum code="8" count="32">Ordered/Results not available</enum><enum code="3" count="6">Borderline</enum></stats></total></variable><variable id="phv00192472.v3.p3" var_name="PRDY" calculated_type="integer" reported_type="integer"><description>F130 Days to Progesterone receptor assay</description><total><subject_profile><sex><female>9763</female></sex></subject_profile><stats><stat n="9763" nulls="1694" mean="3303" sd="1953" median="3185" min="1" max="7945"/><example count="11">764</example><example count="10">3480</example><example count="7">5447</example><example count="7">4554</example><example count="7">1148</example><example count="7">3753</example><example count="7">4914</example><example count="7">5584</example><example count="7">2337</example><example count="7">3082</example></stats></total></variable><variable id="phv00192472.v3.p3.c1" var_name="PRDY" calculated_type="integer" reported_type="integer"><description>F130 Days to Progesterone receptor assay</description><total><subject_profile><sex><female>9049</female></sex></subject_profile><stats><stat n="9049" nulls="1470" mean="3453" sd="1930" median="3409" min="1" max="7945"/><example count="10">3480</example><example count="8">764</example><example count="7">5447</example><example count="7">4554</example><example count="7">3753</example><example count="7">5584</example><example count="7">4732</example><example count="7">5316</example><example count="6">2625</example><example count="6">2947</example></stats></total></variable><variable id="phv00192472.v3.p3.c2" var_name="PRDY" calculated_type="integer" reported_type="integer"><description>F130 Days to Progesterone receptor assay</description><total><subject_profile><sex><female>714</female></sex></subject_profile><stats><stat n="714" nulls="224" mean="1413" sd="1044" median="1236" min="8" max="7090"/><example count="3">451</example><example count="3">944</example><example count="3">743</example><example count="3">595</example><example count="3">1148</example><example count="3">373</example><example count="3">764</example><example count="2">233</example><example count="2">463</example><example count="2">57</example></stats></total></variable><variable id="phv00192473.v3.p3" var_name="PRTYPE" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Type of Progesterone receptor assay</description><total><subject_profile><sex><female>9759</female></sex></subject_profile><stats><stat n="9759" nulls="1698" mean_count="2440" sd="4230" median_count="439" min_count="111" max_count="8770"/><enum code="2" count="8770">ICC/IHC</enum><enum code="9" count="742">Unknown</enum><enum code="8" count="136">Other</enum><enum code="1" count="111">fmol/mg protein</enum></stats></total></variable><variable id="phv00192473.v3.p3.c1" var_name="PRTYPE" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Type of Progesterone receptor assay</description><total><subject_profile><sex><female>9046</female></sex></subject_profile><stats><stat n="9046" nulls="1473" mean_count="2262" sd="3939" median_count="401.5" min_count="87" max_count="8156"/><enum code="2" count="8156">ICC/IHC</enum><enum code="9" count="671">Unknown</enum><enum code="8" count="132">Other</enum><enum code="1" count="87">fmol/mg protein</enum></stats></total></variable><variable id="phv00192473.v3.p3.c2" var_name="PRTYPE" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Type of Progesterone receptor assay</description><total><subject_profile><sex><female>713</female></sex></subject_profile><stats><stat n="713" nulls="225" mean_count="178.3" sd="291.9" median_count="47.5" min_count="4" max_count="614"/><enum code="2" count="614">ICC/IHC</enum><enum code="9" count="71">Unknown</enum><enum code="1" count="24">fmol/mg protein</enum><enum code="8" count="4">Other</enum></stats></total></variable><variable id="phv00192474.v3.p3" var_name="HER2NEU" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Her 2/Neu</description><comment>Not collected on early versions of F130.</comment><total><subject_profile><sex><female>9523</female></sex></subject_profile><stats><stat n="9523" nulls="1934" mean_count="1905" sd="2555" median_count="1044" min_count="80" max_count="6237"/><enum code="2" count="6237">Negative</enum><enum code="9" count="2062">Unknown/Not done</enum><enum code="1" count="1044">Positive</enum><enum code="8" count="100">Ordered/Results not available</enum><enum code="3" count="80">Borderline</enum></stats></total></variable><variable id="phv00192474.v3.p3.c1" var_name="HER2NEU" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Her 2/Neu</description><comment>Not collected on early versions of F130.</comment><total><subject_profile><sex><female>8943</female></sex></subject_profile><stats><stat n="8943" nulls="1576" mean_count="1789" sd="2425" median_count="942" min_count="74" max_count="5904"/><enum code="2" count="5904">Negative</enum><enum code="9" count="1937">Unknown/Not done</enum><enum code="1" count="942">Positive</enum><enum code="8" count="86">Ordered/Results not available</enum><enum code="3" count="74">Borderline</enum></stats></total></variable><variable id="phv00192474.v3.p3.c2" var_name="HER2NEU" calculated_type="enum_integer" reported_type="encoded value"><description>F130 Her 2/Neu</description><comment>Not collected on early versions of F130.</comment><total><subject_profile><sex><female>580</female></sex></subject_profile><stats><stat n="580" nulls="358" mean_count="116" sd="132.2" median_count="102" min_count="6" max_count="333"/><enum code="2" count="333">Negative</enum><enum code="9" count="125">Unknown/Not done</enum><enum code="1" count="102">Positive</enum><enum code="8" count="14">Ordered/Results not available</enum><enum code="3" count="6">Borderline</enum></stats></total></variable><variable id="phv00192475.v3.p3" var_name="HER2NEUDY" calculated_type="integer" reported_type="integer"><description>F130 Days to HER 2/NEU</description><comment>Not collected on early versions of F130.</comment><total><subject_profile><sex><female>7399</female></sex></subject_profile><stats><stat n="7399" nulls="4058" mean="3621" sd="1825" median="3522" min="7" max="7923"/><example count="8">2114</example><example count="7">3753</example><example count="7">3480</example><example count="7">3082</example><example count="6">5447</example><example count="6">1722</example><example count="6">2821</example><example count="6">2597</example><example count="6">2630</example><example count="6">3263</example></stats></total></variable><variable id="phv00192475.v3.p3.c1" var_name="HER2NEUDY" calculated_type="integer" reported_type="integer"><description>F130 Days to HER 2/NEU</description><comment>Not collected on early versions of F130.</comment><total><subject_profile><sex><female>6957</female></sex></subject_profile><stats><stat n="6957" nulls="3562" mean="3739" sd="1799" median="3690" min="7" max="7923"/><example count="7">3753</example><example count="7">3480</example><example count="6">5447</example><example count="6">2114</example><example count="6">2821</example><example count="6">2597</example><example count="6">3263</example><example count="6">5584</example><example count="6">3082</example><example count="6">2793</example></stats></total></variable><variable id="phv00192475.v3.p3.c2" var_name="HER2NEUDY" calculated_type="integer" reported_type="integer"><description>F130 Days to HER 2/NEU</description><comment>Not collected on early versions of F130.</comment><total><subject_profile><sex><female>442</female></sex></subject_profile><stats><stat n="442" nulls="496" mean="1767" sd="1079" median="1639" min="8" max="7090"/><example count="2">1421</example><example count="2">2204</example><example count="2">2114</example><example count="2">602</example><example count="2">2751</example><example count="2">3274</example><example count="2">1148</example><example count="2">1223</example><example count="2">2477</example><example count="2">1542</example></stats></total></variable></data_table>
